Trials / Conditions / Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
4 registered clinical trials studyying Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer NCT06901531 | Astellas Pharma Global Development, Inc. | Phase 3 |
| Recruiting | A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophagea NCT06902545 | Astellas Pharma Korea, Inc. | — |
| Active Not Recruiting | A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subje NCT03653507 | Astellas Pharma Global Development, Inc. | Phase 3 |
| Active Not Recruiting | A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastri NCT03504397 | Astellas Pharma Global Development, Inc. | Phase 3 |